Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 201–225 of 566 matching trials (filtered from 7,816) · page 9 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
DORA and LP in Alzheimer's Disease Biomarkers NCT06274528 Lemborexant 10 mg; Lemborexant 20mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 201 | University of Minnesota OTHER |
2026-07-13 |
|
Biomarkers for Cognitive Decline in Intracerebral Hemorrhage NCT06836141 MRI; Blood Draw; Cognitive Test Runs in: United States · 1 site |
NA other |
RECRUITING | 118 | Rush University Medical Center OTHER |
2026-07-13 |
|
Moving Yourself in Space and Time: MYSTIC NCT07697664 Complex Rhythmic Movement Sequences (CRMS) Sessions Runs in: United States · 1 site |
NA other |
RECRUITING | 210 | Emory University OTHER |
2026-07-13 |
|
Paradoxical Lucidity in Severe End-Stage Dementia NCT05234866 Runs in: United States · 1 site |
NA other |
RECRUITING | 520 | NYU Langone Health OTHER |
2026-07-10 |
|
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) NCT05462106 Placebo (Study Part 1a); ACI-24.060 at Dose A in Study Part 1a; ACI... Runs in: Spain; United Kingdom; United States · 26 sites |
PHASE1|PHASE2 other |
RECRUITING | 304 | AC Immune SA INDUSTRY |
2026-07-10 |
|
Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias NCT07638046 Mindfulness-based walking; Walking-only Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 54 | University of South Carolina OTHER |
2026-07-10 |
|
Low-Dose Radiotherapy for Alzheimer's Disease NCT07693140 Low Dose Radiation Therapy Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 50 | Evan Thomas OTHER |
2026-07-09 |
|
Dual Task Perturbation Training for OAwMCI NCT04938349 Dual task perturbation training Runs in: United States · 1 site |
NA other |
RECRUITING | 142 | University of Illinois at Chicago OTHER |
2026-07-08 |
|
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia NCT07182357 Dementia Care Management Checklist for Hospice Transitions Runs in: United States · 1 site |
NA other |
RECRUITING | 96 | New York University OTHER |
2026-07-08 |
|
Digital Tools to Support Healthcare Decision Making NCT07485725 Project 3, Phase 2: Clinical Trial Runs in: United States · 3 sites |
NA other |
RECRUITING | 120 | Weill Medical College of Cornell University OTHER |
2026-07-08 |
|
Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline NCT06246929 MBCT+w; ALED Runs in: United States · 1 site |
NA other |
RECRUITING | 400 | Massachusetts General Hospital OTHER |
2026-07-07 |
|
Voice Technology-Based Self-Management Intervention NCT06982261 Voice-activated smart speakers Runs in: United States · 1 site |
NA other |
RECRUITING | 20 | Emory University OTHER |
2026-07-07 |
|
Epidemiology and Biomarker Study in Alzheimer's Disease NCT07142954 P-tau217 Test Runs in: Japan; United States · 4 sites |
PHASE3 other |
RECRUITING | 3,400 | Eli Lilly and Company INDUSTRY |
2026-07-07 |
|
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). NCT07602582 Donanemab; Placebo Runs in: Japan; Puerto Rico; United States · 59 sites |
PHASE3 anti-amyloid-antibody |
RECRUITING | 550 | Eli Lilly and Company INDUSTRY |
2026-07-07 |
|
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease NCT04576793 11C-ER176; 18F-MK6240; 18F-Florbetaben; Lumbar Puncture Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 100 | Columbia University OTHER |
2026-07-06 |
|
Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment NCT05858008 Time-restricted eating Runs in: United States · 1 site |
NA other |
RECRUITING | 15 | Julie Pendergast OTHER |
2026-07-06 |
|
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) NCT05980949 KarXT Runs in: Argentina; Belgium; Brazil; Bulgaria; Canada; Chile; Chin... · 429 sites |
PHASE3 other |
RECRUITING | 1,000 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company INDUSTRY |
2026-07-06 |
|
The Care for America's Aging Study NCT06021704 Enhanced home health aide training in dementia and dementia-related... Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 120 | Massachusetts General Hospital OTHER |
2026-07-06 |
|
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease NCT06189963 SNK01; Placebo Runs in: Canada; United States · 8 sites |
PHASE1|PHASE2 other |
RECRUITING | 36 | NKGen Biotech, Inc. INDUSTRY |
2026-07-02 |
|
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes? NCT07546409 Ketone Monoester (KE); Placebo Runs in: United States · 2 sites |
NA other |
RECRUITING | 20 | University of Alabama at Birmingham OTHER |
2026-07-02 |
|
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood NCT07681401 Financial Counseling and Advocacy Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | University of Utah OTHER |
2026-07-02 |
|
18F-mFBG Cardiac Uptake With Lewy Body Dementia NCT07176286 18F-MFBG Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 20 | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) INDUSTRY |
2026-07-01 |
|
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies NCT07240805 Runs in: United States · 2 sites |
NA other |
NOT_YET_RECRUITING | 60 | BioSensics INDUSTRY |
2026-07-01 |
|
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) NCT06947941 KarXT; KarX-EC; KarXT + KarX-EC Arm Matching Placebo Runs in: Australia; Canada; Japan; United Kingdom; United States · 22 sites |
PHASE3 other |
RECRUITING | 325 | Bristol-Myers Squibb INDUSTRY |
2026-06-30 |
|
Neurologic Stem Cell Treatment Study NCT02795052 Intravenous and Intranasal BMSC Runs in: United Arab Emirates; United States · 3 sites |
NA other |
RECRUITING | 500 | MD Stem Cells INDUSTRY |
2026-06-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial